Researchers develop point-of-care device to facilitate monitoring of hereditary and hepatic metabolic disorders
Ammonium is a biomarker used to diagnose a series of rare hereditary metabolic disorders, such as the primary disorders of the urea cycle and different organic acidemias, as well as other metabolic and environmental conditions affecting the liver's function, which can cause a secondary dysfunction of the urea cycle.
Source: news-medical.net